Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Wallemacq

Showing results (71-80 of 138) with videos related to

Pageof 14
Sort By:
Pediatric Transplantation|May 10, 2002
Efficacy and pharmacokinetics of tacrolimus oral suspension in pediatric liver transplant recipientsRaymond Reding, Etienne Sokal, Killick Paul, et al.
Public Health Nutrition|January 18, 2013
Iodine and iron status of pregnant women in Lubumbashi, Democratic Republic of CongoLaurence Habimana, Kabange E Twite, Pierre Wallemacq, et al.
Thrombosis Research|August 17, 2002
Hyperhomocysteinemia and venous thromboembolism: a risk factor more prevalent in the elderly and in idiopathic casesPhilippe Hainaut, Carine Jaumotte, David Verhelst, et al.
Pharmacogenomics|September 10, 2011
Effect of a new functional CYP3A4 polymorphism on calcineurin inhibitors' dose requirements and trough blood levels in stable renal transplant patientsLaure Elens, Ron H van Schaik, Nadtha Panin, et al.
British Journal of Clinical Pharmacology|October 18, 2012
Statistical tools for dose individualization of mycophenolic acid and tacrolimus co-administered during the first month after renal transplantationFlora T Musuamba, Michel Mourad, Vincent Haufroid, et al.
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine|December 26, 2002
Effervescent paracetamol poisoning: a case reportFranck Verschuren, Frédéric Thys, Xavier Wittebole, et al.
Clinical Pharmacokinetics|October 13, 2009
Limited sampling models and Bayesian estimation for mycophenolic acid area under the curve prediction in stable renal transplant patients co-medicated with ciclosporin or sirolimusFlora T Musuamba, Annick Rousseau, Jean-Louis Bosmans, et al.
Clinical Biochemistry|April 17, 2012
Population pharmacokinetics of four β-lactams in critically ill septic patients comedicated with amikacinIsabelle K Delattre, Flora T Musuamba, Philippe Jacqmin, et al.
Journal of Clinical Pharmacology|December 31, 2011
A simultaneous d-optimal designed study for population pharmacokinetic analyses of mycophenolic Acid and tacrolimus early after renal transplantationFlora Tshinanu Musuamba, Michel Mourad, Vincent Haufroid, et al.
Clinical Chemistry and Laboratory Medicine|October 13, 2006
The influence of genetic polymorphisms of cytochrome P450 3A5 and ABCB1 on starting dose- and weight-standardized tacrolimus trough concentrations after kidney transplantation in relation to renal functionMichel Mourad, Pierre Wallemacq, Martine De Meyer, et al.
Pageof 14

Showing results (71-80 of 138) with videos related to

Sort By:
Pageof 14
Pediatric Transplantation|May 10, 2002
Efficacy and pharmacokinetics of tacrolimus oral suspension in pediatric liver transplant recipientsRaymond Reding, Etienne Sokal, Killick Paul, et al.
Public Health Nutrition|January 18, 2013
Iodine and iron status of pregnant women in Lubumbashi, Democratic Republic of CongoLaurence Habimana, Kabange E Twite, Pierre Wallemacq, et al.
Thrombosis Research|August 17, 2002
Hyperhomocysteinemia and venous thromboembolism: a risk factor more prevalent in the elderly and in idiopathic casesPhilippe Hainaut, Carine Jaumotte, David Verhelst, et al.
Pharmacogenomics|September 10, 2011
Effect of a new functional CYP3A4 polymorphism on calcineurin inhibitors' dose requirements and trough blood levels in stable renal transplant patientsLaure Elens, Ron H van Schaik, Nadtha Panin, et al.
British Journal of Clinical Pharmacology|October 18, 2012
Statistical tools for dose individualization of mycophenolic acid and tacrolimus co-administered during the first month after renal transplantationFlora T Musuamba, Michel Mourad, Vincent Haufroid, et al.
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine|December 26, 2002
Effervescent paracetamol poisoning: a case reportFranck Verschuren, Frédéric Thys, Xavier Wittebole, et al.
Clinical Pharmacokinetics|October 13, 2009
Limited sampling models and Bayesian estimation for mycophenolic acid area under the curve prediction in stable renal transplant patients co-medicated with ciclosporin or sirolimusFlora T Musuamba, Annick Rousseau, Jean-Louis Bosmans, et al.
Clinical Biochemistry|April 17, 2012
Population pharmacokinetics of four β-lactams in critically ill septic patients comedicated with amikacinIsabelle K Delattre, Flora T Musuamba, Philippe Jacqmin, et al.
Journal of Clinical Pharmacology|December 31, 2011
A simultaneous d-optimal designed study for population pharmacokinetic analyses of mycophenolic Acid and tacrolimus early after renal transplantationFlora Tshinanu Musuamba, Michel Mourad, Vincent Haufroid, et al.
Clinical Chemistry and Laboratory Medicine|October 13, 2006
The influence of genetic polymorphisms of cytochrome P450 3A5 and ABCB1 on starting dose- and weight-standardized tacrolimus trough concentrations after kidney transplantation in relation to renal functionMichel Mourad, Pierre Wallemacq, Martine De Meyer, et al.
Pageof 14